Global Prostacyclin Drug Supply, Demand and Key Producers, 2024-2030

Global Prostacyclin Drug Supply, Demand and Key Producers, 2024-2030

Page: 104

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Prostacyclin Drug market size is expected to reach $ 3168.1 million by 2030, rising at a market growth of 3.8% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.

This report studies the global Prostacyclin Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Prostacyclin Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prostacyclin Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Prostacyclin Drug total production and demand, 2019-2030, (K Units)
Global Prostacyclin Drug total production value, 2019-2030, (USD Million)
Global Prostacyclin Drug production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Prostacyclin Drug consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Prostacyclin Drug domestic production, consumption, key domestic manufacturers and share
Global Prostacyclin Drug production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Prostacyclin Drug production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Prostacyclin Drug production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Prostacyclin Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma and Bayer AG, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Prostacyclin Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Prostacyclin Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Prostacyclin Drug Market, Segmentation by Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium

Global Prostacyclin Drug Market, Segmentation by Application
For Injection
For Oral
For Inhalation

Companies Profiled:
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG

Key Questions Answered
1. How big is the global Prostacyclin Drug market?
2. What is the demand of the global Prostacyclin Drug market?
3. What is the year over year growth of the global Prostacyclin Drug market?
4. What is the production and production value of the global Prostacyclin Drug market?
5. Who are the key producers in the global Prostacyclin Drug market?
btl

Table of Contents

1 Supply Summary
1.1 Prostacyclin Drug Introduction
1.2 World Prostacyclin Drug Supply & Forecast
1.2.1 World Prostacyclin Drug Production Value (2019 & 2023 & 2030)
1.2.2 World Prostacyclin Drug Production (2019-2030)
1.2.3 World Prostacyclin Drug Pricing Trends (2019-2030)
1.3 World Prostacyclin Drug Production by Region (Based on Production Site)
1.3.1 World Prostacyclin Drug Production Value by Region (2019-2030)
1.3.2 World Prostacyclin Drug Production by Region (2019-2030)
1.3.3 World Prostacyclin Drug Average Price by Region (2019-2030)
1.3.4 North America Prostacyclin Drug Production (2019-2030)
1.3.5 Europe Prostacyclin Drug Production (2019-2030)
1.3.6 China Prostacyclin Drug Production (2019-2030)
1.3.7 Japan Prostacyclin Drug Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Prostacyclin Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Prostacyclin Drug Major Market Trends

2 Demand Summary
2.1 World Prostacyclin Drug Demand (2019-2030)
2.2 World Prostacyclin Drug Consumption by Region
2.2.1 World Prostacyclin Drug Consumption by Region (2019-2024)
2.2.2 World Prostacyclin Drug Consumption Forecast by Region (2025-2030)
2.3 United States Prostacyclin Drug Consumption (2019-2030)
2.4 China Prostacyclin Drug Consumption (2019-2030)
2.5 Europe Prostacyclin Drug Consumption (2019-2030)
2.6 Japan Prostacyclin Drug Consumption (2019-2030)
2.7 South Korea Prostacyclin Drug Consumption (2019-2030)
2.8 ASEAN Prostacyclin Drug Consumption (2019-2030)
2.9 India Prostacyclin Drug Consumption (2019-2030)

3 World Prostacyclin Drug Manufacturers Competitive Analysis
3.1 World Prostacyclin Drug Production Value by Manufacturer (2019-2024)
3.2 World Prostacyclin Drug Production by Manufacturer (2019-2024)
3.3 World Prostacyclin Drug Average Price by Manufacturer (2019-2024)
3.4 Prostacyclin Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Prostacyclin Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Prostacyclin Drug in 2023
3.5.3 Global Concentration Ratios (CR8) for Prostacyclin Drug in 2023
3.6 Prostacyclin Drug Market: Overall Company Footprint Analysis
3.6.1 Prostacyclin Drug Market: Region Footprint
3.6.2 Prostacyclin Drug Market: Company Product Type Footprint
3.6.3 Prostacyclin Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Prostacyclin Drug Production Value Comparison
4.1.1 United States VS China: Prostacyclin Drug Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Prostacyclin Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Prostacyclin Drug Production Comparison
4.2.1 United States VS China: Prostacyclin Drug Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Prostacyclin Drug Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Prostacyclin Drug Consumption Comparison
4.3.1 United States VS China: Prostacyclin Drug Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Prostacyclin Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Prostacyclin Drug Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Prostacyclin Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Prostacyclin Drug Production Value (2019-2024)
4.4.3 United States Based Manufacturers Prostacyclin Drug Production (2019-2024)
4.5 China Based Prostacyclin Drug Manufacturers and Market Share
4.5.1 China Based Prostacyclin Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Prostacyclin Drug Production Value (2019-2024)
4.5.3 China Based Manufacturers Prostacyclin Drug Production (2019-2024)
4.6 Rest of World Based Prostacyclin Drug Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Prostacyclin Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Prostacyclin Drug Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Prostacyclin Drug Production (2019-2024)

5 Market Analysis by Type
5.1 World Prostacyclin Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Epoprostenol Sodium
5.2.2 Treprostinil
5.2.3 Iloprost
5.2.4 Beraprost Sodium
5.3 Market Segment by Type
5.3.1 World Prostacyclin Drug Production by Type (2019-2030)
5.3.2 World Prostacyclin Drug Production Value by Type (2019-2030)
5.3.3 World Prostacyclin Drug Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Prostacyclin Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 For Injection
6.2.2 For Oral
6.2.3 For Inhalation
6.3 Market Segment by Application
6.3.1 World Prostacyclin Drug Production by Application (2019-2030)
6.3.2 World Prostacyclin Drug Production Value by Application (2019-2030)
6.3.3 World Prostacyclin Drug Average Price by Application (2019-2030)

7 Company Profiles
7.1 United Therapeutics
7.1.1 United Therapeutics Details
7.1.2 United Therapeutics Major Business
7.1.3 United Therapeutics Prostacyclin Drug Product and Services
7.1.4 United Therapeutics Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 United Therapeutics Recent Developments/Updates
7.1.6 United Therapeutics Competitive Strengths & Weaknesses
7.2 Actelion (J & J)
7.2.1 Actelion (J & J) Details
7.2.2 Actelion (J & J) Major Business
7.2.3 Actelion (J & J) Prostacyclin Drug Product and Services
7.2.4 Actelion (J & J) Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Actelion (J & J) Recent Developments/Updates
7.2.6 Actelion (J & J) Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Prostacyclin Drug Product and Services
7.3.4 GSK Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Teva
7.4.1 Teva Details
7.4.2 Teva Major Business
7.4.3 Teva Prostacyclin Drug Product and Services
7.4.4 Teva Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Teva Recent Developments/Updates
7.4.6 Teva Competitive Strengths & Weaknesses
7.5 Toray
7.5.1 Toray Details
7.5.2 Toray Major Business
7.5.3 Toray Prostacyclin Drug Product and Services
7.5.4 Toray Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Toray Recent Developments/Updates
7.5.6 Toray Competitive Strengths & Weaknesses
7.6 Tide Pharma
7.6.1 Tide Pharma Details
7.6.2 Tide Pharma Major Business
7.6.3 Tide Pharma Prostacyclin Drug Product and Services
7.6.4 Tide Pharma Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Tide Pharma Recent Developments/Updates
7.6.6 Tide Pharma Competitive Strengths & Weaknesses
7.7 Bayer AG
7.7.1 Bayer AG Details
7.7.2 Bayer AG Major Business
7.7.3 Bayer AG Prostacyclin Drug Product and Services
7.7.4 Bayer AG Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Bayer AG Recent Developments/Updates
7.7.6 Bayer AG Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Prostacyclin Drug Industry Chain
8.2 Prostacyclin Drug Upstream Analysis
8.2.1 Prostacyclin Drug Core Raw Materials
8.2.2 Main Manufacturers of Prostacyclin Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Prostacyclin Drug Production Mode
8.6 Prostacyclin Drug Procurement Model
8.7 Prostacyclin Drug Industry Sales Model and Sales Channels
8.7.1 Prostacyclin Drug Sales Model
8.7.2 Prostacyclin Drug Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Prostacyclin Drug Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Prostacyclin Drug Production Value by Region (2019-2024) & (USD Million)
Table 3. World Prostacyclin Drug Production Value by Region (2025-2030) & (USD Million)
Table 4. World Prostacyclin Drug Production Value Market Share by Region (2019-2024)
Table 5. World Prostacyclin Drug Production Value Market Share by Region (2025-2030)
Table 6. World Prostacyclin Drug Production by Region (2019-2024) & (K Units)
Table 7. World Prostacyclin Drug Production by Region (2025-2030) & (K Units)
Table 8. World Prostacyclin Drug Production Market Share by Region (2019-2024)
Table 9. World Prostacyclin Drug Production Market Share by Region (2025-2030)
Table 10. World Prostacyclin Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Prostacyclin Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Prostacyclin Drug Major Market Trends
Table 13. World Prostacyclin Drug Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Prostacyclin Drug Consumption by Region (2019-2024) & (K Units)
Table 15. World Prostacyclin Drug Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Prostacyclin Drug Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Prostacyclin Drug Producers in 2023
Table 18. World Prostacyclin Drug Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Prostacyclin Drug Producers in 2023
Table 20. World Prostacyclin Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Prostacyclin Drug Company Evaluation Quadrant
Table 22. World Prostacyclin Drug Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Prostacyclin Drug Production Site of Key Manufacturer
Table 24. Prostacyclin Drug Market: Company Product Type Footprint
Table 25. Prostacyclin Drug Market: Company Product Application Footprint
Table 26. Prostacyclin Drug Competitive Factors
Table 27. Prostacyclin Drug New Entrant and Capacity Expansion Plans
Table 28. Prostacyclin Drug Mergers & Acquisitions Activity
Table 29. United States VS China Prostacyclin Drug Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Prostacyclin Drug Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Prostacyclin Drug Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Prostacyclin Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Prostacyclin Drug Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Prostacyclin Drug Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Prostacyclin Drug Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Prostacyclin Drug Production Market Share (2019-2024)
Table 37. China Based Prostacyclin Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Prostacyclin Drug Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Prostacyclin Drug Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Prostacyclin Drug Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Prostacyclin Drug Production Market Share (2019-2024)
Table 42. Rest of World Based Prostacyclin Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Prostacyclin Drug Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Prostacyclin Drug Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Prostacyclin Drug Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Prostacyclin Drug Production Market Share (2019-2024)
Table 47. World Prostacyclin Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Prostacyclin Drug Production by Type (2019-2024) & (K Units)
Table 49. World Prostacyclin Drug Production by Type (2025-2030) & (K Units)
Table 50. World Prostacyclin Drug Production Value by Type (2019-2024) & (USD Million)
Table 51. World Prostacyclin Drug Production Value by Type (2025-2030) & (USD Million)
Table 52. World Prostacyclin Drug Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Prostacyclin Drug Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Prostacyclin Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Prostacyclin Drug Production by Application (2019-2024) & (K Units)
Table 56. World Prostacyclin Drug Production by Application (2025-2030) & (K Units)
Table 57. World Prostacyclin Drug Production Value by Application (2019-2024) & (USD Million)
Table 58. World Prostacyclin Drug Production Value by Application (2025-2030) & (USD Million)
Table 59. World Prostacyclin Drug Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Prostacyclin Drug Average Price by Application (2025-2030) & (US$/Unit)
Table 61. United Therapeutics Basic Information, Manufacturing Base and Competitors
Table 62. United Therapeutics Major Business
Table 63. United Therapeutics Prostacyclin Drug Product and Services
Table 64. United Therapeutics Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. United Therapeutics Recent Developments/Updates
Table 66. United Therapeutics Competitive Strengths & Weaknesses
Table 67. Actelion (J & J) Basic Information, Manufacturing Base and Competitors
Table 68. Actelion (J & J) Major Business
Table 69. Actelion (J & J) Prostacyclin Drug Product and Services
Table 70. Actelion (J & J) Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Actelion (J & J) Recent Developments/Updates
Table 72. Actelion (J & J) Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Prostacyclin Drug Product and Services
Table 76. GSK Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Teva Basic Information, Manufacturing Base and Competitors
Table 80. Teva Major Business
Table 81. Teva Prostacyclin Drug Product and Services
Table 82. Teva Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Teva Recent Developments/Updates
Table 84. Teva Competitive Strengths & Weaknesses
Table 85. Toray Basic Information, Manufacturing Base and Competitors
Table 86. Toray Major Business
Table 87. Toray Prostacyclin Drug Product and Services
Table 88. Toray Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Toray Recent Developments/Updates
Table 90. Toray Competitive Strengths & Weaknesses
Table 91. Tide Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Tide Pharma Major Business
Table 93. Tide Pharma Prostacyclin Drug Product and Services
Table 94. Tide Pharma Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Tide Pharma Recent Developments/Updates
Table 96. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 97. Bayer AG Major Business
Table 98. Bayer AG Prostacyclin Drug Product and Services
Table 99. Bayer AG Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 100. Global Key Players of Prostacyclin Drug Upstream (Raw Materials)
Table 101. Prostacyclin Drug Typical Customers
Table 102. Prostacyclin Drug Typical Distributors
List of Figure
Figure 1. Prostacyclin Drug Picture
Figure 2. World Prostacyclin Drug Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Prostacyclin Drug Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Prostacyclin Drug Production (2019-2030) & (K Units)
Figure 5. World Prostacyclin Drug Average Price (2019-2030) & (US$/Unit)
Figure 6. World Prostacyclin Drug Production Value Market Share by Region (2019-2030)
Figure 7. World Prostacyclin Drug Production Market Share by Region (2019-2030)
Figure 8. North America Prostacyclin Drug Production (2019-2030) & (K Units)
Figure 9. Europe Prostacyclin Drug Production (2019-2030) & (K Units)
Figure 10. China Prostacyclin Drug Production (2019-2030) & (K Units)
Figure 11. Japan Prostacyclin Drug Production (2019-2030) & (K Units)
Figure 12. Prostacyclin Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 15. World Prostacyclin Drug Consumption Market Share by Region (2019-2030)
Figure 16. United States Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 17. China Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 18. Europe Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 19. Japan Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 20. South Korea Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 22. India Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Prostacyclin Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Prostacyclin Drug Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Prostacyclin Drug Markets in 2023
Figure 26. United States VS China: Prostacyclin Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Prostacyclin Drug Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Prostacyclin Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Prostacyclin Drug Production Market Share 2023
Figure 30. China Based Manufacturers Prostacyclin Drug Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Prostacyclin Drug Production Market Share 2023
Figure 32. World Prostacyclin Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Prostacyclin Drug Production Value Market Share by Type in 2023
Figure 34. Epoprostenol Sodium
Figure 35. Treprostinil
Figure 36. Iloprost
Figure 37. Beraprost Sodium
Figure 38. World Prostacyclin Drug Production Market Share by Type (2019-2030)
Figure 39. World Prostacyclin Drug Production Value Market Share by Type (2019-2030)
Figure 40. World Prostacyclin Drug Average Price by Type (2019-2030) & (US$/Unit)
Figure 41. World Prostacyclin Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Prostacyclin Drug Production Value Market Share by Application in 2023
Figure 43. For Injection
Figure 44. For Oral
Figure 45. For Inhalation
Figure 46. World Prostacyclin Drug Production Market Share by Application (2019-2030)
Figure 47. World Prostacyclin Drug Production Value Market Share by Application (2019-2030)
Figure 48. World Prostacyclin Drug Average Price by Application (2019-2030) & (US$/Unit)
Figure 49. Prostacyclin Drug Industry Chain
Figure 50. Prostacyclin Drug Procurement Model
Figure 51. Prostacyclin Drug Sales Model
Figure 52. Prostacyclin Drug Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Prostacyclin Drug Supply, Demand and Key Producers, 2024-2030

Global Prostacyclin Drug Supply, Demand and Key Producers, 2024-2030

Page: 104

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Prostacyclin Drug market size is expected to reach $ 3168.1 million by 2030, rising at a market growth of 3.8% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.

This report studies the global Prostacyclin Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Prostacyclin Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prostacyclin Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Prostacyclin Drug total production and demand, 2019-2030, (K Units)
Global Prostacyclin Drug total production value, 2019-2030, (USD Million)
Global Prostacyclin Drug production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Prostacyclin Drug consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Prostacyclin Drug domestic production, consumption, key domestic manufacturers and share
Global Prostacyclin Drug production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Prostacyclin Drug production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Prostacyclin Drug production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Prostacyclin Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma and Bayer AG, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Prostacyclin Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Prostacyclin Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Prostacyclin Drug Market, Segmentation by Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium

Global Prostacyclin Drug Market, Segmentation by Application
For Injection
For Oral
For Inhalation

Companies Profiled:
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG

Key Questions Answered
1. How big is the global Prostacyclin Drug market?
2. What is the demand of the global Prostacyclin Drug market?
3. What is the year over year growth of the global Prostacyclin Drug market?
4. What is the production and production value of the global Prostacyclin Drug market?
5. Who are the key producers in the global Prostacyclin Drug market?
btl

Table of Contents

1 Supply Summary
1.1 Prostacyclin Drug Introduction
1.2 World Prostacyclin Drug Supply & Forecast
1.2.1 World Prostacyclin Drug Production Value (2019 & 2023 & 2030)
1.2.2 World Prostacyclin Drug Production (2019-2030)
1.2.3 World Prostacyclin Drug Pricing Trends (2019-2030)
1.3 World Prostacyclin Drug Production by Region (Based on Production Site)
1.3.1 World Prostacyclin Drug Production Value by Region (2019-2030)
1.3.2 World Prostacyclin Drug Production by Region (2019-2030)
1.3.3 World Prostacyclin Drug Average Price by Region (2019-2030)
1.3.4 North America Prostacyclin Drug Production (2019-2030)
1.3.5 Europe Prostacyclin Drug Production (2019-2030)
1.3.6 China Prostacyclin Drug Production (2019-2030)
1.3.7 Japan Prostacyclin Drug Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Prostacyclin Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Prostacyclin Drug Major Market Trends

2 Demand Summary
2.1 World Prostacyclin Drug Demand (2019-2030)
2.2 World Prostacyclin Drug Consumption by Region
2.2.1 World Prostacyclin Drug Consumption by Region (2019-2024)
2.2.2 World Prostacyclin Drug Consumption Forecast by Region (2025-2030)
2.3 United States Prostacyclin Drug Consumption (2019-2030)
2.4 China Prostacyclin Drug Consumption (2019-2030)
2.5 Europe Prostacyclin Drug Consumption (2019-2030)
2.6 Japan Prostacyclin Drug Consumption (2019-2030)
2.7 South Korea Prostacyclin Drug Consumption (2019-2030)
2.8 ASEAN Prostacyclin Drug Consumption (2019-2030)
2.9 India Prostacyclin Drug Consumption (2019-2030)

3 World Prostacyclin Drug Manufacturers Competitive Analysis
3.1 World Prostacyclin Drug Production Value by Manufacturer (2019-2024)
3.2 World Prostacyclin Drug Production by Manufacturer (2019-2024)
3.3 World Prostacyclin Drug Average Price by Manufacturer (2019-2024)
3.4 Prostacyclin Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Prostacyclin Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Prostacyclin Drug in 2023
3.5.3 Global Concentration Ratios (CR8) for Prostacyclin Drug in 2023
3.6 Prostacyclin Drug Market: Overall Company Footprint Analysis
3.6.1 Prostacyclin Drug Market: Region Footprint
3.6.2 Prostacyclin Drug Market: Company Product Type Footprint
3.6.3 Prostacyclin Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Prostacyclin Drug Production Value Comparison
4.1.1 United States VS China: Prostacyclin Drug Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Prostacyclin Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Prostacyclin Drug Production Comparison
4.2.1 United States VS China: Prostacyclin Drug Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Prostacyclin Drug Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Prostacyclin Drug Consumption Comparison
4.3.1 United States VS China: Prostacyclin Drug Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Prostacyclin Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Prostacyclin Drug Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Prostacyclin Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Prostacyclin Drug Production Value (2019-2024)
4.4.3 United States Based Manufacturers Prostacyclin Drug Production (2019-2024)
4.5 China Based Prostacyclin Drug Manufacturers and Market Share
4.5.1 China Based Prostacyclin Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Prostacyclin Drug Production Value (2019-2024)
4.5.3 China Based Manufacturers Prostacyclin Drug Production (2019-2024)
4.6 Rest of World Based Prostacyclin Drug Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Prostacyclin Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Prostacyclin Drug Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Prostacyclin Drug Production (2019-2024)

5 Market Analysis by Type
5.1 World Prostacyclin Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Epoprostenol Sodium
5.2.2 Treprostinil
5.2.3 Iloprost
5.2.4 Beraprost Sodium
5.3 Market Segment by Type
5.3.1 World Prostacyclin Drug Production by Type (2019-2030)
5.3.2 World Prostacyclin Drug Production Value by Type (2019-2030)
5.3.3 World Prostacyclin Drug Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Prostacyclin Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 For Injection
6.2.2 For Oral
6.2.3 For Inhalation
6.3 Market Segment by Application
6.3.1 World Prostacyclin Drug Production by Application (2019-2030)
6.3.2 World Prostacyclin Drug Production Value by Application (2019-2030)
6.3.3 World Prostacyclin Drug Average Price by Application (2019-2030)

7 Company Profiles
7.1 United Therapeutics
7.1.1 United Therapeutics Details
7.1.2 United Therapeutics Major Business
7.1.3 United Therapeutics Prostacyclin Drug Product and Services
7.1.4 United Therapeutics Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 United Therapeutics Recent Developments/Updates
7.1.6 United Therapeutics Competitive Strengths & Weaknesses
7.2 Actelion (J & J)
7.2.1 Actelion (J & J) Details
7.2.2 Actelion (J & J) Major Business
7.2.3 Actelion (J & J) Prostacyclin Drug Product and Services
7.2.4 Actelion (J & J) Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Actelion (J & J) Recent Developments/Updates
7.2.6 Actelion (J & J) Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Prostacyclin Drug Product and Services
7.3.4 GSK Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Teva
7.4.1 Teva Details
7.4.2 Teva Major Business
7.4.3 Teva Prostacyclin Drug Product and Services
7.4.4 Teva Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Teva Recent Developments/Updates
7.4.6 Teva Competitive Strengths & Weaknesses
7.5 Toray
7.5.1 Toray Details
7.5.2 Toray Major Business
7.5.3 Toray Prostacyclin Drug Product and Services
7.5.4 Toray Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Toray Recent Developments/Updates
7.5.6 Toray Competitive Strengths & Weaknesses
7.6 Tide Pharma
7.6.1 Tide Pharma Details
7.6.2 Tide Pharma Major Business
7.6.3 Tide Pharma Prostacyclin Drug Product and Services
7.6.4 Tide Pharma Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Tide Pharma Recent Developments/Updates
7.6.6 Tide Pharma Competitive Strengths & Weaknesses
7.7 Bayer AG
7.7.1 Bayer AG Details
7.7.2 Bayer AG Major Business
7.7.3 Bayer AG Prostacyclin Drug Product and Services
7.7.4 Bayer AG Prostacyclin Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Bayer AG Recent Developments/Updates
7.7.6 Bayer AG Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Prostacyclin Drug Industry Chain
8.2 Prostacyclin Drug Upstream Analysis
8.2.1 Prostacyclin Drug Core Raw Materials
8.2.2 Main Manufacturers of Prostacyclin Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Prostacyclin Drug Production Mode
8.6 Prostacyclin Drug Procurement Model
8.7 Prostacyclin Drug Industry Sales Model and Sales Channels
8.7.1 Prostacyclin Drug Sales Model
8.7.2 Prostacyclin Drug Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Prostacyclin Drug Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Prostacyclin Drug Production Value by Region (2019-2024) & (USD Million)
Table 3. World Prostacyclin Drug Production Value by Region (2025-2030) & (USD Million)
Table 4. World Prostacyclin Drug Production Value Market Share by Region (2019-2024)
Table 5. World Prostacyclin Drug Production Value Market Share by Region (2025-2030)
Table 6. World Prostacyclin Drug Production by Region (2019-2024) & (K Units)
Table 7. World Prostacyclin Drug Production by Region (2025-2030) & (K Units)
Table 8. World Prostacyclin Drug Production Market Share by Region (2019-2024)
Table 9. World Prostacyclin Drug Production Market Share by Region (2025-2030)
Table 10. World Prostacyclin Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Prostacyclin Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Prostacyclin Drug Major Market Trends
Table 13. World Prostacyclin Drug Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Prostacyclin Drug Consumption by Region (2019-2024) & (K Units)
Table 15. World Prostacyclin Drug Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Prostacyclin Drug Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Prostacyclin Drug Producers in 2023
Table 18. World Prostacyclin Drug Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Prostacyclin Drug Producers in 2023
Table 20. World Prostacyclin Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Prostacyclin Drug Company Evaluation Quadrant
Table 22. World Prostacyclin Drug Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Prostacyclin Drug Production Site of Key Manufacturer
Table 24. Prostacyclin Drug Market: Company Product Type Footprint
Table 25. Prostacyclin Drug Market: Company Product Application Footprint
Table 26. Prostacyclin Drug Competitive Factors
Table 27. Prostacyclin Drug New Entrant and Capacity Expansion Plans
Table 28. Prostacyclin Drug Mergers & Acquisitions Activity
Table 29. United States VS China Prostacyclin Drug Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Prostacyclin Drug Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Prostacyclin Drug Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Prostacyclin Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Prostacyclin Drug Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Prostacyclin Drug Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Prostacyclin Drug Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Prostacyclin Drug Production Market Share (2019-2024)
Table 37. China Based Prostacyclin Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Prostacyclin Drug Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Prostacyclin Drug Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Prostacyclin Drug Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Prostacyclin Drug Production Market Share (2019-2024)
Table 42. Rest of World Based Prostacyclin Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Prostacyclin Drug Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Prostacyclin Drug Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Prostacyclin Drug Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Prostacyclin Drug Production Market Share (2019-2024)
Table 47. World Prostacyclin Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Prostacyclin Drug Production by Type (2019-2024) & (K Units)
Table 49. World Prostacyclin Drug Production by Type (2025-2030) & (K Units)
Table 50. World Prostacyclin Drug Production Value by Type (2019-2024) & (USD Million)
Table 51. World Prostacyclin Drug Production Value by Type (2025-2030) & (USD Million)
Table 52. World Prostacyclin Drug Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Prostacyclin Drug Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Prostacyclin Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Prostacyclin Drug Production by Application (2019-2024) & (K Units)
Table 56. World Prostacyclin Drug Production by Application (2025-2030) & (K Units)
Table 57. World Prostacyclin Drug Production Value by Application (2019-2024) & (USD Million)
Table 58. World Prostacyclin Drug Production Value by Application (2025-2030) & (USD Million)
Table 59. World Prostacyclin Drug Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Prostacyclin Drug Average Price by Application (2025-2030) & (US$/Unit)
Table 61. United Therapeutics Basic Information, Manufacturing Base and Competitors
Table 62. United Therapeutics Major Business
Table 63. United Therapeutics Prostacyclin Drug Product and Services
Table 64. United Therapeutics Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. United Therapeutics Recent Developments/Updates
Table 66. United Therapeutics Competitive Strengths & Weaknesses
Table 67. Actelion (J & J) Basic Information, Manufacturing Base and Competitors
Table 68. Actelion (J & J) Major Business
Table 69. Actelion (J & J) Prostacyclin Drug Product and Services
Table 70. Actelion (J & J) Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Actelion (J & J) Recent Developments/Updates
Table 72. Actelion (J & J) Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Prostacyclin Drug Product and Services
Table 76. GSK Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Teva Basic Information, Manufacturing Base and Competitors
Table 80. Teva Major Business
Table 81. Teva Prostacyclin Drug Product and Services
Table 82. Teva Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Teva Recent Developments/Updates
Table 84. Teva Competitive Strengths & Weaknesses
Table 85. Toray Basic Information, Manufacturing Base and Competitors
Table 86. Toray Major Business
Table 87. Toray Prostacyclin Drug Product and Services
Table 88. Toray Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Toray Recent Developments/Updates
Table 90. Toray Competitive Strengths & Weaknesses
Table 91. Tide Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Tide Pharma Major Business
Table 93. Tide Pharma Prostacyclin Drug Product and Services
Table 94. Tide Pharma Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Tide Pharma Recent Developments/Updates
Table 96. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 97. Bayer AG Major Business
Table 98. Bayer AG Prostacyclin Drug Product and Services
Table 99. Bayer AG Prostacyclin Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 100. Global Key Players of Prostacyclin Drug Upstream (Raw Materials)
Table 101. Prostacyclin Drug Typical Customers
Table 102. Prostacyclin Drug Typical Distributors
List of Figure
Figure 1. Prostacyclin Drug Picture
Figure 2. World Prostacyclin Drug Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Prostacyclin Drug Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Prostacyclin Drug Production (2019-2030) & (K Units)
Figure 5. World Prostacyclin Drug Average Price (2019-2030) & (US$/Unit)
Figure 6. World Prostacyclin Drug Production Value Market Share by Region (2019-2030)
Figure 7. World Prostacyclin Drug Production Market Share by Region (2019-2030)
Figure 8. North America Prostacyclin Drug Production (2019-2030) & (K Units)
Figure 9. Europe Prostacyclin Drug Production (2019-2030) & (K Units)
Figure 10. China Prostacyclin Drug Production (2019-2030) & (K Units)
Figure 11. Japan Prostacyclin Drug Production (2019-2030) & (K Units)
Figure 12. Prostacyclin Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 15. World Prostacyclin Drug Consumption Market Share by Region (2019-2030)
Figure 16. United States Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 17. China Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 18. Europe Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 19. Japan Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 20. South Korea Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 22. India Prostacyclin Drug Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Prostacyclin Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Prostacyclin Drug Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Prostacyclin Drug Markets in 2023
Figure 26. United States VS China: Prostacyclin Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Prostacyclin Drug Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Prostacyclin Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Prostacyclin Drug Production Market Share 2023
Figure 30. China Based Manufacturers Prostacyclin Drug Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Prostacyclin Drug Production Market Share 2023
Figure 32. World Prostacyclin Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Prostacyclin Drug Production Value Market Share by Type in 2023
Figure 34. Epoprostenol Sodium
Figure 35. Treprostinil
Figure 36. Iloprost
Figure 37. Beraprost Sodium
Figure 38. World Prostacyclin Drug Production Market Share by Type (2019-2030)
Figure 39. World Prostacyclin Drug Production Value Market Share by Type (2019-2030)
Figure 40. World Prostacyclin Drug Average Price by Type (2019-2030) & (US$/Unit)
Figure 41. World Prostacyclin Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Prostacyclin Drug Production Value Market Share by Application in 2023
Figure 43. For Injection
Figure 44. For Oral
Figure 45. For Inhalation
Figure 46. World Prostacyclin Drug Production Market Share by Application (2019-2030)
Figure 47. World Prostacyclin Drug Production Value Market Share by Application (2019-2030)
Figure 48. World Prostacyclin Drug Average Price by Application (2019-2030) & (US$/Unit)
Figure 49. Prostacyclin Drug Industry Chain
Figure 50. Prostacyclin Drug Procurement Model
Figure 51. Prostacyclin Drug Sales Model
Figure 52. Prostacyclin Drug Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
jiaGou

Add To Cart

gouMai

Buy Now